Study Finds Epilepsy Patients Feel Better After Daily CBD Regimen

[et_pb_section bb_built=”1″][et_pb_row][et_pb_column type=”4_4″][et_pb_text]

Study Finds Epilepsy Patients Feel Better After Daily CBD Regimen


WASHINGTON DC — Patients with intractable epilepsy in Alabama felt better overall one year after initiating a daily cannabidiol (CBD) regimen, according to a study presented here, despite also reporting declining social support and more stressful events over the course of the year.

Epilepsy patients started taking daily doses of CBD. One year later, a significant number felt better.

The state-funded study did not directly assess CBD’s impact. “I can’t say that” CBD was a factor, said lead researcher Barbara Hansen, now a sociology professor at Henderson State University (Arkansas). She did confirm that every patient in the study was indeed administered CBD, when she spoke to at the American Epilepsy Society annual meeting earlier in December.

Intractable epilepsy is “a seizure disorder in which a patient’s seizures fail to come under control with treatment,” according to the University of Rochester Medical Center. The seizures are also referred to as “refractory” or “uncontrolled.”

Researchers with the University of Alabama at Birmingham (where Hansen was then a doctoral student) enrolled patients in April 2015 in an open-label study, distributing 100 mg/ml CBD solutions. The participants took initial doses of 5 mg of the solution per each kg they weighed every day, via twice-daily spoonfuls. Patients could increase their daily dosage by 5 mg every two weeks, up to a maximum of 50 mg per kg per day.